These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2011676)

  • 21. [Pericardial effusion during the therapy of Crohn's disease with 5-aminosalicylic acid].
    Weber P; Becker EW; Jenss H
    Dtsch Med Wochenschr; 1988 Nov; 113(46):1806-7. PubMed ID: 3191853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncoated versus coated 5-aminosalicylic acid in Crohn's disease.
    Bossi A; Giuliani GE; Del Poggio P; Fenili D; Ragaini S
    Lancet; 1989 Feb; 1(8632):276. PubMed ID: 2563434
    [No Abstract]   [Full Text] [Related]  

  • 23. [Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
    Gendre JP; Mary JY; Florent C; Modigliani R; Colombel JF; Soulé JC; Galmiche JP; Lerebours E; Descos L; Viteau JM
    Ann Gastroenterol Hepatol (Paris); 1993 Oct; 29(5):251-6. PubMed ID: 8250520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial nephritis associated with 5-aminosalicylic acid.
    Witte T; Olbricht CJ; Koch KM
    Nephron; 1994; 67(4):481-2. PubMed ID: 7969684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
    Netzer P
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemistry, pharmacology, pharmacokinetics, and clinical applications of mesalamine for the treatment of inflammatory bowel disease.
    Small RE; Schraa CC
    Pharmacotherapy; 1994; 14(4):385-98. PubMed ID: 7937276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is maintenance therapy effective in Crohn's disease?
    Greenberger NJ; Miner PB
    Lancet; 1994 Oct; 344(8927):900-1. PubMed ID: 7934340
    [No Abstract]   [Full Text] [Related]  

  • 28. [Conservative therapy of Crohn disease--reliable measures based on clinical studies].
    Hartmann F; Plauth M
    Internist (Berl); 1991 Sep; 32(9):518-23. PubMed ID: 1683663
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mesalazine in Crohn disease].
    Linnestad P
    Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3252. PubMed ID: 2256041
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug choice in preventing postoperative Crohn's disease.
    Korelitz BI
    Gastroenterology; 1996 Feb; 110(2):652-3. PubMed ID: 8566620
    [No Abstract]   [Full Text] [Related]  

  • 31. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K; Fischer C; Klotz U; Heinkel K
    Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.
    Messori A; Brignola C; Trallori G; Rampazzo R; Bardazzi G; Belloli C; d'Albasio G; De Simone G; Martini N
    Am J Gastroenterol; 1994 May; 89(5):692-8. PubMed ID: 8172139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.
    Mahida YR; Jewell DP
    Digestion; 1990; 45(2):88-92. PubMed ID: 2190851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mesalazine].
    Engelhardt K; Mohr K
    Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute pancreatitis due to 5-aminosalicylic acid].
    Romero Castro R; Jiménez Sáenz M; Pellicer Bautista FJ; Domínguez Palomo S; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 1991 Mar; 79(3):219-21. PubMed ID: 2043409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 37. [New developments in therapy with 5-aminosalicylic acid preparations in ulcerative colitis and Crohn disease].
    Kruis W
    Z Gastroenterol Verh; 1991 Mar; 26():154-6. PubMed ID: 1714132
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute pancreatitis due to 5-aminosalicylate.
    Sachedina B; Saibil F; Cohen LB; Whittey J
    Ann Intern Med; 1989 Mar; 110(6):490-2. PubMed ID: 2465715
    [No Abstract]   [Full Text] [Related]  

  • 39. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
    Steinhart AH; Hemphill D; Greenberg GR
    Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asacol in inflammatory bowel disease.
    Oakes RA
    N Z Med J; 1987 May; 100(824):325. PubMed ID: 3451096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.